Contralateral axillary lymph node metastasis as the first evidence of locally recurrent breast carcinoma

Shabnam Jaffer, Alisan B. Goldfarb, Jay E. Gold, Arnold Szporn, Ira J. Bleiweiss

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Background. Carcinoma of the breast infrequently presents initially as axillary adenopathy. In such cases, after biopsy proves the presence of metastatic carcinoma, the primary tumor generally is assumed to be in the ipsilateral breast, despite negative mammographic findings and the lack of a clinically palpable breast mass. Methods. The authors recently studied a case of a 50‐year‐old woman in whom recurrent neuroendocrine carcinoma of the breast presented as a contralateral axillary lymph node metastasis. After mastectomy ipsilateral to the metastasis proved negative for tumor, a histologic, comparison of the previous contralateral tumor with that in the lymph node was performed, followed by biopsy of the clinically and mammographically negative original lumpectomy site. Results. Histologic and immunohistochemical studies proved that the original, metastatic, and locally recurrent tumors were identical, sharing unusual neuroendocrine features. The patient is currently disease free after chemotherapy. Conclusion. Contralateral mammary carcinoma should be considered in the workup of a patient who presents with evidence of an axillary lymph node metastasis. Locally recurrent breast carcinoma may be clinically and mammographically occult. Histologic review of prior biopsy material and comparison with current tissue is essential in proper patient management. Cancer 1995;75:2875–8.

Original languageEnglish
Pages (from-to)2875-2878
Number of pages4
JournalCancer
Volume75
Issue number12
DOIs
StatePublished - 15 Jun 1995

Keywords

  • axillary lymphadenopathy
  • breast carcinoma
  • contralateral metastasis
  • neuroendocrine carcinoma of breast

Fingerprint

Dive into the research topics of 'Contralateral axillary lymph node metastasis as the first evidence of locally recurrent breast carcinoma'. Together they form a unique fingerprint.

Cite this